A New Turning Point in Lung Cancer Treatment, Inspired by Mussels Jan. 9, 2025 — Scientists have developed inhalable lung cancer therapeutics utilizing mucoadhesive proteinic ... Milestone in ...

The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with ...

Dosing has started in a clinical evaluating peluntamig, which targets DLL3 and CD47, combined with chemotherapy in patients ...

Unlike drinking, Kashmir has a huge population that smokes and it is reflecting in the numbers of the lung cancers ...

Sep. 25, 2024 — Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive ... Experimental mRNA Cancer ...

Multidrug resistance in cancer can be overcome by combining a drug that blocks a key enzyme with another anticancer drug, ...

The time of day of immunotherapy infusions does appear to affect patient outcomes. But convincing the wider oncology ...

The head of the Alabama Parole Board on Thursday questioned why the state should grant parole to a 68-year-old dying man who ...

It takes around 8 years for a squamous cell carcinoma, for example ... 8, 9 Once symptoms appear they are often ignored by patients, delaying the diagnosis and treatment even further. The reasons for ...

Interventional Oncology Market Interventional Oncology Market Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "Interventional ...

The treatment of hepatocellular carcinoma (HCC) has made progress due to immune checkpoint inhibitors (ICIs), but still many patients present innate or acquired resistance to ICIs, thus there is a ...

In its 10-K report, Iovance Biotherapeutics highlighted its commercialization efforts for Amtagvi, the first product within ...